Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Tralokinumab – Updates in Atopic Dermatitis
8
Mins
January 2026
A summary of new data on tralokinumab in atopic dermatitis, presented at conferences/symposia held between September and October 2024.
Read more
10
Mins
14 Mar 2019
Discover the Potential: Exploring New Frontiers of IL-23 Inhibitors
Affecting up to 11.4% of the population worldwide, psoriasis is one of the most common chronic autoinflammatory diseases.
10
Mins
12 Feb 2019
Translating Evidence to Practice: From Clinical Research to Real-World Experience
The goal of this programme is to support dermatologists to improve the management of patients with moderate-to-severe AD and bring together clinicians…
5
Mins
7 Feb 2019
Dimethyl Fumarate in Psoriasis Therapy
This presentation by Dr Weisenseel considered the role of fumaric acid esters (FAE) in plaque psoriasis.
9
Mins
29 Jan 2019
Unlocking the Potential of Immuno-Oncology in Advanced Cutaneous Squamous Cell Carcinoma: Role of Checkpoint Blockade
The rising incidence of CSCC presents a major challenge for healthcare systems and the frequency and impact of progression to advanced disease is…
8
Mins
13 Dec 2018
Translating Knowledge of IL-23 Targeting into New Solutions for Psoriasis Treatment
Following a brief introduction by Prof Lambert, the symposium started with an in-depth review of the current unmet needs in the clinical management of…
10
Mins
30 Oct 2018
PASI 90/100, DLQI 0/1, and IL-17 Receptor/Cytokine: Does it Make a Difference and Are We Ambitious Enough?
The main objectives of the symposium were to review recent evidence on what difference targeting Psoriasis Area Severity Index (PASI) 90 or 100 and…
9
Mins
30 Oct 2018
Navigating the Road to Psoriasis Control in Women: Strategies to Optimise the Reproductive Journey
The importance of discussions around the management of women of childbearing age with psoriasis, an issue that has been largely neglected for many years…
10
Mins
30 Oct 2018
Is Complete Skin Clearance in Psoriasis the Answer?
Prof Reich outlined the new understanding of psoriasis pathogenesis, with IL-23 rather than IL-12 considered the pivotal cytokine pathway. This…
Loading posts...
« Previous
1
…
6
7
8
9
10
…
12
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View